MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disease characterized by neuronal loss, aggregation of senile plaques derived from amyloid beta (Aβ) peptides, abnormal phosphorylation of tau protein and cognitive decline in the hippocampus or cortex [1,2].